FDA seeks probe into communications between staff and Biogen over Alzheimer’s drug

BREAKING NEWS: FDA seeks probe into communications between its staff and Biogen after controversial approval of Alzheimer’s drug FDA commissioner Janet Woodcock has asked for a probe into her staff’s communications with Biogen Biogen’s Aduhelm received FDA approval for Alzhiemer’s disease in early June despite limited data that it worked in clinical trials   By Mansur Shaheen … Read more

Biogen conference in Boston led to roughly 20,000 coronavirus infections in two months 

A strategy meeting of a Massachusetts-based drug company played a much greater role in spreading the novel coronavirus than previously believed, a new study finds. The international Biogen Inc conference, held at the Boston Marriott Long Wharf hotel in late February, led to roughly 20,000 cases of COVID-19 across the US in two months. That … Read more